Screening and identification of biomarkers associated with clinicopathological parameters and prognosis in oral squamous cell carcinoma

Wu,Qiqi; Cao,Ruoyan; Chen,Juan; Xie,Xiaoli

doi:10.3892/etm.2019.7998

Screening and identification of biomarkers associated with clinicopathological parameters and prognosis in oral squamous cell carcinoma

Authors:
- Qiqi Wu
- Ruoyan Cao
- Juan Chen
- Xiaoli Xie
View Affiliations

Affiliations: Department of Endodontics, Xiangya Stomatological Hospital, Xiangya School of Stomatology, Central South University, Changsha, Hunan 410083, P.R. China, Department of Prosthodontics, Xiangya Stomatological Hospital, Xiangya School of Stomatology, Central South University, Changsha, Hunan 410083, P.R. China, Department of Oral and Maxillofacial Surgery, Xiangya Stomatological Hospital, Xiangya School of Stomatology, Central South University, Changsha, Hunan 410083, P.R. China
Published online on: September 11, 2019 https://doi.org/10.3892/etm.2019.7998
Pages: 3579-3587
Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Oral squamous cell carcinoma (OSCC) is a major type of malignant tumor of the oral cavity. Despite marked advances in the management and diagnosis of OSCC, the associated overall survival ratio has only exhibited a modest increase in recent years. The present study aimed to identify potential crucial genes associated with clinical features and prognosis for OSCC, and to provide a basis for further investigation. RNA‑sequencing data and corresponding clinical information were downloaded from The Cancer Genome Atlas database and differentially expressed mRNAs (DEmRNAs) were identified using the edgeR package. Bioinformatics analysis was performed to identify differentially expressed clinical features‑associated mRNAs (CFmRNAs) and enhance the current knowledge of the function of them. Functional enrichment analysis and protein‑protein interplay (PPI) network analysis were then performed to better understand CFmRNAs. Survival‑associated genes were analyzed with Kaplan‑Meier survival curves and the log‑rank test. A total of 2,013 DEmRNAs between OSCC samples and normal tissues were identified, 180 of which were associated with clinical features. A total of 17 GO terms and 4 KEGG pathways were significantly enriched in functional enrichment analysis. A total of 4 hub genes (albumin, statherin, neurotensin and mucin 7) were identified in the PPI network analysis. A total of 6 genes (DDB1 and CUL4 associated factor 4 like 2, opiorphin prepropeptide, R3H domain containing like, transmembrane phosphatase with tensin homology, actin like 8 and protocadherin α 11) were observed to have an influence on survival. The DEmRNAs identified may have a crucial role in the genesis and development of OSCC and may be further developed for diagnostic, therapeutic and prognostic applications for OSCC in the future.

View Figures

View References

1	Shimomura H, Sasahira T, Nakashima C, Shimomura-Kurihara M and Kirita T: Downregulation of DHRS9 is associated with poor prognosis in oral squamous cell carcinoma. Pathology. 50:642–647. 2018. View Article : Google Scholar : PubMed/NCBI
2	Sandulache VC, Michikawa C, Kataria P, Gleber-Netto FO, Bell D, Trivedi S, Rao X, Wang J, Zhao M, Jasser S, et al: High-risk TP53 mutations are associated with extranodal extension in oral cavity squamous cell carcinoma. Clin Cancer Res. 24:1727–1733. 2018. View Article : Google Scholar : PubMed/NCBI
3	Peng Q, Deng Z, Pan H, Gu L, Liu O and Tang Z: Mitogen-activated protein kinase signaling pathway in oral cancer (Review). Oncol Lett. 15:1379–1388. 2018.PubMed/NCBI
4	Sahingur SE and Yeudall WA: Chemokine function in periodontal disease and oral cavity cancer. Front Immunol. 6:2142015. View Article : Google Scholar : PubMed/NCBI
5	Zhao X, Sun S, Zeng X and Cui L: Expression profiles analysis identifies a novel three-mRNA signature to predict overall survival in oral squamous cell carcinoma. Am J Cancer Res. 8:450–461. 2018.PubMed/NCBI
6	Chen PK, Hua CH, Hsu HT, Kuo TM, Chung CM, Lee CP, Tsai MH, Yeh KT and Ko YC: ALPK1 expression is associated with lymph node metastasis and tumor growth in oral squamous cell carcinoma patients. Am J Pathol. 189:190–199. 2019. View Article : Google Scholar : PubMed/NCBI
7	Tang G, Tang Q, Jia L, Xia S, Li J, Chen Y, Li H, Ding X, Wang F, Hou D, et al: High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma. Pathol Res Pract. 214:1606–1612. 2018. View Article : Google Scholar : PubMed/NCBI
8	Zhang H, Liu J, Fu X and Yang A: Identification of key genes and pathways in tongue squamous cell carcinoma using bioinformatics analysis. Med Sci Monit. 23:5924–5932. 2017. View Article : Google Scholar : PubMed/NCBI
9	Wang H, Niu L, Jiang S, Zhai J, Wang P, Kong F and Jin X: Comprehensive analysis of aberrantly expressed profiles of lncRNAs and miRNAs with associated ceRNA network in muscle-invasive bladder cancer. Oncotarget. 7:86174–86185. 2016. View Article : Google Scholar : PubMed/NCBI
10	Lydiatt WM, Patel SG, O'Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, Loomis AM and Shah JP: Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 67:122–137. 2017. View Article : Google Scholar : PubMed/NCBI
11	Gao C, Zhuang J, Zhou C, Ma K, Zhao M, Liu C, Liu L, Li H, Feng F and Sun C: Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The cancer genome atlas. J Cell Physiol. 234:6519–6528. 2019. View Article : Google Scholar : PubMed/NCBI
12	Sarode SC, Sarode GS and Patil S: Role of statherin in oral carcinogenesis. Oral Oncol. 50:e55–e56. 2014. View Article : Google Scholar : PubMed/NCBI
13	de Sousa-Pereira P, Amado F, Abrantes J, Ferreira R, Esteves PJ and Vitorino R: An evolutionary perspective of mammal salivary peptide families: Cystatins, histatins, statherin and PRPs. Arch Oral Biol. 58:451–458. 2013. View Article : Google Scholar : PubMed/NCBI
14	Sabatini LM, Carlock LR, Johnson GW and Azen EA: cDNA cloning and chromosomal localization (4q11-13) of a gene for statherin, a regulator of calcium in saliva. Am J Hum Genet. 41:1048–1060. 1987.PubMed/NCBI
15	Contucci AM, Inzitari R, Agostino S, Vitali A, Fiorita A, Cabras T, Scarano E and Messana I: Statherin levels in saliva of patients with precancerous and cancerous lesions of the oral cavity: A preliminary report. Oral Dis. 11:95–99. 2005. View Article : Google Scholar : PubMed/NCBI
16	Souazé F, Dupouy S, Viardot-Foucault V, Bruyneel E, Attoub S, Gespach C, Gompel A and Forgez P: Expression of neurotensin and NT1 receptor in human breast cancer: A potential role in tumor progression. Cancer Res. 66:6243–6249. 2006. View Article : Google Scholar : PubMed/NCBI
17	Wu Z, Galmiche A, Liu J, Stadler N, Wendum D, Segal-Bendirdjian E, Paradis V and Forgez P: Neurotensin regulation induces overexpression and activation of EGFR in HCC and restores response to erlotinib and sorafenib. Cancer Lett. 388:73–84. 2017. View Article : Google Scholar : PubMed/NCBI
18	Morgat C, Mishra AK, Varshney R, Allard M, Fernandez P and Hindié E: Targeting neuropeptide receptors for cancer imaging and therapy: Perspectives with bombesin, neurotensin, and neuropeptide-Y receptors. J Nucl Med. 55:1650–1657. 2014. View Article : Google Scholar : PubMed/NCBI
19	Dupouy S, Viardot-Foucault V, Alifano M, Souazé F, Plu-Bureau G, Chaouat M, Lavaur A, Hugol D, Gespach C, Gompel A and Forgez P: The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression. PLoS One. 4:e42232009. View Article : Google Scholar : PubMed/NCBI
20	Younes M, Wu Z, Dupouy S, Lupo AM, Mourra N, Takahashi T, Fléjou JF, Trédaniel J, Régnard JF, Damotte D, et al: Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib. Oncotarget. 5:8252–8269. 2014. View Article : Google Scholar : PubMed/NCBI
21	Ye Y, Long X, Zhang L, Chen J, Liu P, Li H, Wei F, Yu W, Ren X and Yu J: NTS/NTR1 co-expression enhances epithelial-to-mesenchymal transition and promotes tumor metastasis by activating the Wnt/β-catenin signaling pathway in hepatocellular carcinoma. Oncotarget. 7:70303–70322. 2016. View Article : Google Scholar : PubMed/NCBI
22	Xiao P, Long X, Zhang L, Ye Y, Guo J, Liu P, Zhang R, Ning J, Yu W, Wei F and Yu J: Neurotensin/IL-8 pathway orchestrates local inflammatory response and tumor invasion by inducing M2 polarization of Tumor-Associated macrophages and epithelial-mesenchymal transition of hepatocellular carcinoma cells. Oncoimmunology. 7:e14401662018. View Article : Google Scholar : PubMed/NCBI
23	Alos L, Lujan B, Castillo M, Nadal A, Carreras M, Caballero M, de Bolos C and Cardesa A: Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands. Am J Surg Pathol. 29:806–813. 2005. View Article : Google Scholar : PubMed/NCBI
24	NguyenHoang S, Liu Y, Xu L, Chang Y, Zhou L, Liu Z, Lin Z and Xu J: High mucin-7 expression is an independent predictor of adverse clinical outcomes in patients with clear-cell renal cell carcinoma. Tumour Biol. 37:15193–15201. 2016. View Article : Google Scholar : PubMed/NCBI
25	Xu D, Pavlidis P, Thamadilok S, Redwood E, Fox S, Blekhman R, Ruhl S and Gokcumen O: Recent evolution of the salivary mucin MUC7. Sci Rep. 6:317912016. View Article : Google Scholar : PubMed/NCBI
26	Mahomed F: Recent advances in mucin immunohistochemistry in salivary gland tumors and head and neck squamous cell carcinoma. Oral Oncol. 47:797–803. 2011. View Article : Google Scholar : PubMed/NCBI
27	Nagashio R, Ueda J, Ryuge S, Nakashima H, Jiang SX, Kobayashi M, Yanagita K, Katono K, Satoh Y, Masuda N, et al: Diagnostic and prognostic significances of MUC5B and TTF-1 expressions in resected non-small cell lung cancer. Sci Rep. 5:86492015. View Article : Google Scholar : PubMed/NCBI
28	Kumar MH, Sanjai K, Kumarswamy J, Keshavaiah R, Papaiah L and Divya S: Expression of MUC1 mucin in potentially malignant disorders, oral squamous cell carcinoma and normal oral mucosa: An immunohistochemical study. J Oral Maxillofac Pathol. 20:214–218. 2016. View Article : Google Scholar : PubMed/NCBI
29	Thakur A, Tupkari JV, Joy T, Kende PP, Siwach P and Ahire MS: Expression of mucin-1 in oral squamous cell carcinoma and normal oral mucosa: An immunohistochemical study. J Oral Maxillofac Pathol. 22:210–215. 2018. View Article : Google Scholar : PubMed/NCBI
30	Micel LN, Tentler JJ, Smith PG and Eckhardt GS: Role of ubiquitin ligases and the proteasome in oncogenesis: Novel targets for anticancer therapies. J Clin Oncol. 31:1231–1238. 2013. View Article : Google Scholar : PubMed/NCBI
31	Beaty TH, Taub MA, Scott AF, Murray JC, Marazita ML, Schwender H, Parker MM, Hetmanski JB, Balakrishnan P, Mansilla MA, et al: Confirming genes influencing risk to cleft lip with/without cleft palate in a case-parent trio study. Hum Genet. 132:771–781. 2013. View Article : Google Scholar : PubMed/NCBI
32	Wang H, Chen Y, Han J, Meng Q, Xi Q, Wu G and Zhang B: DCAF4L2 promotes colorectal cancer invasion and metastasis via mediating degradation of NFκB negative regulator PPM1B. Am J Transl Res. 8:405–418. 2016.PubMed/NCBI
33	Miller RE, Uwamahoro N and Park JH: PPM1B depletion in U2OS cells supresses cell growth through RB1-E2F1 pathway and stimulates bleomycin-induced cell death. Biochem Biophys Res Commun. 500:391–397. 2018. View Article : Google Scholar : PubMed/NCBI
34	Saitoh E, Taniguchi M, Ochiai A, Kato T, Imai A and Isemura S: Bioactive peptides hidden in human salivary proteins. J Oral Biosciences. 59:71–79. 2017. View Article : Google Scholar
35	Saitoh E, Sega T, Imai A, Isemura S, Kato T, Ochiai A and Taniguchi M: The PBII gene of the human salivary proline-rich protein P-B produces another protein, Q504X8, with an opiorphin homolog, QRGPR. Arch Oral Biol. 88:10–18. 2018. View Article : Google Scholar : PubMed/NCBI
36	Lang Z, Wu Y, Pan X, Qu G and Zhang T: Study of differential gene expression between invasive multifocal/multicentric and unifocal breast cancer. J BUON. 23:134–142. 2018.PubMed/NCBI
37	Kuemmel A, Simon P, Breitkreuz A, Röhlig J, Luxemburger U, Elsässer A, Schmidt LH, Sebastian M, Sahin U, Türeci Ö and Buhl R: Humoral immune responses of lung cancer patients against the Transmembrane phosphatase with TEnsin homology (TPTE). Lung Cancer. 90:334–341. 2015. View Article : Google Scholar : PubMed/NCBI
38	Yao J, Caballero OL, Yung WK, Weinstein JN, Riggins GJ, Strausberg RL and Zhao Q: Tumor subtype-specific cancer-testis antigens as potential biomarkers and immunotherapeutic targets for cancers. Cancer Immunol Res. 2:371–379. 2014. View Article : Google Scholar : PubMed/NCBI
39	Cuffel C, Rivals JP, Zaugg Y, Salvi S, Seelentag W, Speiser DE, Liénard D, Monnier P, Romero P, Bron L and Rimoldi D: Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma. Int J Cancer. 128:2625–2634. 2011. View Article : Google Scholar : PubMed/NCBI
40	Piotti KC, Scognamiglio T, Chiu R and Chen YT: Expression of cancer/testis (CT) antigens in squamous cell carcinoma of the head and neck: Evaluation as markers of squamous dysplasia. Pathol Res Pract. 209:721–726. 2013. View Article : Google Scholar : PubMed/NCBI
41	Li B, Zhu J and Meng L: High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma. Mol Med Rep. 19:877–884. 2019.PubMed/NCBI
42	Freitas M, Malheiros S, Stávale JN, Biassi TP, Zamunér FT, de Souza Begnami M, Soares FA and Vettore AL: Expression of cancer/testis antigens is correlated with improved survival in glioblastoma. Oncotarget. 4:636–646. 2013. View Article : Google Scholar : PubMed/NCBI
43	Mahmoud AM: Cancer testis antigens as immunogenic and oncogenic targets in breast cancer. Immunotherapy. 10:769–778. 2018. View Article : Google Scholar : PubMed/NCBI